Physician No program year No payments reported Source: CMS Open Payments, 2026 publication

Howard Zisser

Internal Medicine Santa Barbara, CA

NPI 1467561605 CMS profile 21552

2219 Bath St, Santa Barbara, CA 93105

Open in the dashboard

General payments

None reported

Research payments

Paid to them · None reported

Ownership & investment interest

None reported

The CMS Open Payments record contains no reported payments to Howard Zisser of Santa Barbara, CA.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

Other Internal Medicine in California

Andrew Cheng

Internal Medicine · South San Francisco, CA

Tung Ngo

Internal Medicine · Newport Beach, CA

Christian Eversull

Internal Medicine · Stanford, CA

Christian Sandrock

Internal Medicine · Sacramento, CA

Hatim Husain

Internal Medicine · San Diego, CA

Teck Ling

Internal Medicine · Palo Alto, CA

Related records

Internal Medicine in California

Practitioners in the same specialty and state, ranked by reported value.

All Internal Medicine

Everyone recorded under this specialty, nationwide.

Doctors in California

Every practitioner in the state with a reported payment.

How to read this page

What each amount means, and what it does not mean.

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.